|
[1]Rubenfeld GD,Caldwell E,Peabody E,Weaver J, Martin DP,Neff M,Stern EJ,Hudson LD.Incidence and outcomes of acute lunjury.
N Engl J Med.2005;353:1685-1693
[2]洪心容、黃世勳.實用藥草入門圖鑑 展讀文化 2007
[3]Zang,M. and Su,C.H.Ganoderma camphoratum, a new taxon in genus Ganderma from Taiwan. Chna Acta Bot Yunnancia. 1990;12:395-396
[4]Chang,T.T. and Chou, W.N.Antrodia cinnamomea sp. nov. on Cinnamomum kanehirai in Taiwan.Mycol.res.1995;99:756-758
[5]張東柱、杜英齊、洪志昇、王隆耀.新圖解牛樟菇 活石文化 2015
[6]Cherng,I .H.and Chiang,H.C. Three new triterpenoids from Antrodia cinnamomea. J.Natural Products.1995; 58:365-371
[7]吳德鵬:樟芝微量成分的研究 國立臺灣師範大學化學研究所論文 1995
[8]簡秋源、姜洪哲、陳淑貞:牛樟菇培養性狀及其三?衛?成分分析之研究，牛樟生物學及育林技術研討會論文集 林業叢刊第72號:133-137
[9]Mizuno,T.The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan(Review).Inter.J.Med.Mushrooms.1990;1:9-29
[10]Schultz MJ,Haitsma JJ,Zhang H,Slutsky AS.Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia—a review.Crit Care Med.2006;34:871-877
[11]Tsushima K, King LS, Aggarwal NR, De Gorordo A, D''Alessio FR, Kubo K. Acute lung injury review. Intern Med. 2009;48:621-630
[12]Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.The acute respiratory distress syndrome network.N Engl J Med.2000;342:1301-1308
[13]Roch A,Guervilly C,Papazian L.Fluid management in acute lung injury and ards.Ann Intensive Care.2011;1:16
[14]Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349
[15]Dreyfuss D, Ricard JD. Acute lung injury and bacterial infection. Clin Chest Med. 2005;26:105-112
[16]Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med. 2011;17:293-307
[17]Balamayooran G, Batra S, Fessler MB, Happel KI, Jeyaseelan S. Mechanisms of neutrophil accumulation in the lungs against bacteria. Am J Respir Cell Mol Biol. 2010;43:5-16
[18]Abraham E. Neutrophils and acute lung injury. Crit Care Med. 2003;31:S195
[19]Abraham E, Carmody A, Shenkar R, Arcaroli J. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1137-1145
[20]Sapru A, Wiemels JL, Witte JS, Ware LB, Matthay MA. Acute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein c and fibrinolytic pathways. Intensive Care Med. 2006;32:1293-1303
[21]Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care. 2001;7:1-7
[22]Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper KV, Jr. Fibroproliferative phase of ards. Clinical findings and effects of corticosteroids. Chest.1991;100:943-952
[23]Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000;161:454-462
[24]Fukuda Y, Ishizaki M, Masuda Y, Kimura G, Kawanami O, Masugi Y. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol. 1987;126:171-182
[25]Martin C, Papazian L, Payan MJ, Saux P, Gouin F. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest. 1995;107:196-200
[26]Bellingan GJ. The pulmonary physician in critical care * 6: The pathogenesis of ali/ards. Thorax. 2002;57:540-546
[27]Chen H, Bai C, Wang X. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 2010;4:773-783
[28]Bastarache JA, Blackwell TS. Development of animal models for the acute respiratory distress syndrome. Dis Model Mech. 2009;2:218-223
[29]Wang HM, Bodenstein M, Markstaller K. Overview of the pathology of three widely used animal models of acute lung injury. Eur Surg Res. 2008;40:305-316
[30]Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295:L379-399
[31]麥麗敏、祁業榮、廖美華、鍾麗琴、戴瑄、黃玉琪、呂國昀.解剖生理學 華杏出版社 2009.
[32]Eliopoulos AG, Dumitru CD, Wang CC, Cho J, Tsichlis PN: Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. The EMBO journal 2002;21(18):4831-4840.
[33]Carol A. Feghali PD, and Timothy M. Wright, M.D1: Cytokine in acute and chronic inflammation. Frontiers in Bioscience 2 January 1, 1997.
[34]E FH, Pstein MD: Cytokine pathway and joint inflammation in rheumatoid arthritis. Mechanisms of Disease.
[35]Spector WG, Willoughby DA. The inflammatory response. Bacteriol Rev,1963; 27: 117-54.
[36]Guzel S, Serin O, Guzel EC, Buyuk B, Yılmaz G, G?吰enen G. Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor [corrected] of matrix metalloproteinase-1 in myocardial infarction. Korean J Intern Med,2013; 28: 165-73.
[37]Narasimhalu K, Lee J, Leong YL, Ma L, De Silva DA, Wong MC, Chang HM, Chen C. Inflammatory markers and their association with post stroke cognitive decline. International Journal of Stroke, 2015;10(4) : 513-8.
[38]Annemie Bogaerts,Maksudbek Yusupov, Jonas Van der Paal,Christof C. W. Verlackt, Erik C. Neyts. Reactive Molecular Dynamics Simulations fora Better Insight in Plasma Medicine.Plasma Process. Polym. 2014; 11:1156–116
[39]洪哲明、葉明憲、李國華、葉家舟：肺部相關複方對肺部細胞產生發炎細胞激素之研究台灣中醫家庭醫學雜誌2007；2（1）：25-35
[40]Mechanisms of bacterial pathogenicity:Endotoxins.Todar''s Online Textbook ofBacteriology,2008 Kenneth TodarUniversity of Wisconsin-Madison Department of Bacteriology.
[41]施景耀、陳冠傑、陳順佳，內毒素與敗血症，國立嘉義大學網站。
[42]Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319-23.
[43]Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, Gatanaga T, Granger GA, Lentz R, Raab H .Molecular cloning and expression of a receptor for human tumor necrosis factor. 1990;Cell. 61(2), 361-370.
[44]Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science. 1990;248(4958), 1019-1023.
[45]Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W (1990) Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61(2):351-359.
[46]Zhang F, Yu W, Hargrove JL, Greenspan P, Dean RG, Taylor EW, Hartle DK,Inhibition of TNF-alpha induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis. 2002;161(2), 381-386.
[47]Aggarwal BBTumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis. 2000;59 Suppl 1, i6-16.
[48]Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med. 1986;163(6), 1363-1375.
[49]Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, Lotz M,Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol. 1989;142(1), 144-147.
[50]Marlin SD, Springer TA ,Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell. 1987;51(5), 813-9.
[51]Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, HemLer ME, Lobb RR VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 1990;60(4), 577-584.
[52]Springer TA Adhesion receptors of the immune system. Nature.1998; 346(6283), 425-434.
[53]Walz G, Aruffo A, Kolanus W, Bevilacqua M, Seed B Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science. 1990;250(4984), 1132-1135.
[54]鄧富元、龔素芳、夏毅然、高文斌、謝耀東 NF-κB在發炎反應、細胞凋亡與癌症生成過程中的調控。Chin Dent J （中華牙誌） 2006;25(1)：12-24
[55]Scheidereit C. IκB kinase complexes:gateways to NF-Κb activation and transcription. Oncogene 2006;25:6685-6705.
[56]Karin M, Yamamoto Y, Wang QM: The IKK NF-kappa B system: a treasure trove for drug development. Nature reviews Drug discovery 2004;3(1):17-26.
[57]Gasparini C, Feldmann M: NF-kappaB as a target for modulating inflammatory responses. Current pharmaceutical design 2012; 18(35):5735-5745.
[58]Karin M, Yamamoto Y, Wang QM: The IKK NF-kappa B system: a treasure trove for drug development. Nature reviews Drug discovery 2004; 3(1):17-26.
[59]Huang Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX: NF-kappaB precursor, p105, and NF-kappaB inhibitor, IkappaBgamma, are both elevated in Alzheimer disease brain. Neuroscience letters 2005;373(2):115-118.
[60]Zabel U, Baeuerle PA: Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell 1990;61(2):255-265.
[61]Huang Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX: NF-kappaB precursor, p105, and NF-kappaB inhibitor, IkappaBgamma, are both elevated in Alzheimer disease brain. Neuroscience letters 2005;373(2):115-118.
[62]Shih VF, Kearns JD, Basak S, Savinova OV, Ghosh G, Hoffmann A: Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity. Proceedings of the National Academy of Sciences of the United States of America 2009; 106(24):9619-9624.
[63]Lopez-Bojorquez LN, Arechavaleta-Velasco F, Vadillo-Ortega F, Montes-Sanchez D, Ventura-Gallegos JL, Zentella-Dehesa A: NF-kappaB translocation and endothelial cell activation is potentiated by macrophage-released signals co-secreted with TNF-alpha and IL-1beta. Inflammation research : official journal of the European Histamine Research Society [et al] 2004;53(10):567-575.
[64]Gao C, Wang X, Chen L, Wang JH, Gao ZT, Wang H: Knockdown of Bcl-3 Inhibits Cell Growth and Induces DNA Damage in HTLV-1-infected Cells). Asian Pacific journal of cancer prevention : APJCP 2013; 14(1):405-408.
[65]Ben-Neriah Y, Karin M: Inflammation meets cancer, with NF-kappaB as the matchmaker. Nature immunology 2011; 12(8):715-723.
[66]Basith S, Manavalan B, Gosu V, Choi S: Evolutionary, structural and functional interplay of the IkappaB family members. PloS one 2013; 8(1):e54178.
[67]楊念忠 平滑肌細胞中第一型血紅素氧化調控介白素一號所誘發一氧化氮合成之研究，2000
[68]Michel, T., and Feron, O. Perspective series: Nitric oxide and nitric oxide synthases. J. Clin. Invest. 1997;100, 2146-2152.
[69]Nathan, C., and Xie, Q.-W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78, 915-918.
[70]Kunz, D., Műhl, H., Walker, G., and Pfeilschifter, J. Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc. Natl. Acad. Sci.1994; USA 91, 5387-5391.
[71]Perrella, J. A., Yoshizumi, M.,Fen Z., Tsai, J.-C., Hsieh, C.-M., Kourembanas, S., and Lee, M.-E. Transforming growth factor-β1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J. Biol. Chem.1994; 269, 14595-14600
[72]Lecanu, L., and Plotkine, M. Contribution of oxidative stress to excitotoxicity-induced deleterious iNOS in the CNS. Drug Discovery Today .1999;4, 292-293.
[73]Olajide OA, Aderogba MA, Fiebich BL. Mechanisms of anti- inflammatory property of Anacardium occidentale stem bark: inhibition of NF-kappaB and MAPK signalling in the microglia. J Ethnopharmacol. 2013;145(1):42-49.
[74]Lee HS, Ryu DS, Lee GS, Lee DS. Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW 264.7 cells: suppression of NF-kappaB activation and MAPK signaling. J Ethnopharmacol. 2012;140(2):271-276.
[75]Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med,1996; 154: 602-11.
[76]Waetzig V, Herdegen T. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol Sci, 2005;26: 455-61.
[77]Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev,2004; 68: 320-44.
[78]Ono K, Han J. The p38 signal transduction pathway activation and function. Cellular signalling, 2000;12: 1-13.
[79]Zhang YS,Wang MH, Tao K, Chen FZ, Zhao GH, Department of Surgery,Wannan Medical College,Wuhu 241001,Anhui,China;Effect of propofol on pulmonary injury induced by early-stage severe acute pancreatitis in rats[J];Chinese Journal of Clinical Pharmacology and Therapeutics;2009-11
[80]Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1991;144（2）:268–71.
[81]Millar AB, Singer M, Meager A, Foley NM, Johnson NM, Rook GAW. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet. 1989; 2 （8665）:712–4.
[82]Gerard C, Frossard JL, Bhatia M, Saluja A, Gerard NP, Lu B, Steer M. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest. 1997;100 （8） :2022–7.
[83]Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interkeukin-1, interferon, and elastase, in patients with respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992;145 （5） :1016–22.
[84]Siler TM, Swierkosz JE, Hyers TM, Fowler AA, Webster RO. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp Lung Res. 1989;15 （6） :881–94
[85]Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154 （3-1） :602–11.
[86]Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;164 （10-1） :1896–903.
[87]Delhase M, Li N, Karin M. Kinase regulation in inflammatory response. Nature. 2000;406（6794）:367–8.
[88]Meja KK, Seldon PM, Nasuhara Y, Ito K, Barnes PJ, Lindsay MA. p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappaB-independent mechanism. Br J Pharmacol. 2000;131 （6） :1143–53.
[89]Nasuhara Y, Adcock IM, Catley M, Barnes PJ, Newton R. Differential IKK activation and IkBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells: evidence for additional regulatory steps in kB-dependent transcription. J Biol Chem. 1999;274 （28） :19965-72.
[90]Zhang YS,Wang MH, Tao K, Chen FZ, Zhao GH, Department of Surgery,Wannan Medical College,Wuhu 241001,Anhui,China;Effect of propofol on pulmonary injury induced by early-stage severe acute pancreatitis in rats[J];Chinese Journal of Clinical Pharmacology and Therapeutics;2009-11
[91]Huang GJ, Deng JS, Chen CC, Huang CJ, Sung PJ, Huang SS, and Kuo YH. Methanol Extract of Antrodia camphorata Protects against Lipopolysaccharide-Induced Acute Lung Injury by Suppressing NF-κB and MAPK Pathways in Mice. J. Agric. Food Chem. 2014; 62, 5321−5329
[92]Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1991;144（2）:268–71.
[93]Millar AB, Singer M, Meager A, Foley NM, Johnson NM, Rook GAW. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet. 1989; 2 （8665） :712–4.
[94]De Bosscher K, Haegeman G, Elewaut D. Targeting inflammation using selective glucocorticoid receptor modulators. Curr Opin Pharmacol 2010; 10: 497–504.
|